Skip to content

The effect of oral Pregabalin on post herniorrhaphy pain relief

Evaluation of the efficacy and safety of oral pregabalin on post Lichtenstein herniorrhaphy pain relief in comparison with control group, Mousavi Hospital, Zanjan, 2014-2015

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015041821817N1
Enrollment
60
Registered
2015-07-11
Start date
2014-10-02
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia. Unilateral or unspecified femoral hernia, without obstruction or gangrene

Interventions

Intervention 1: Intervention group: receive single-dose 300 mg oral pregabalin 2 h before and 150 mg pregabalin 12 and 24 h after surgery in addition to 1 mg per kg of pethidine PRN. Intervention 2:
Treatment - Drugs
Intervention group: receive single-dose 300 mg oral pregabalin 2 h before and 150 mg pregabalin 12 and 24 h after surgery in addition to 1 mg per kg of pethidine PRN.
Control group: just receive 1 mg per kg of pethidine PRN.

Sponsors

Zanjan University of Medical Siences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: Male patients over 18 years old; unilateral inguinal hernia; elective surgery. Exclusion criteria: Emergency surgery; incarceration; simultaneous other operations; history of diabetes mellitus; peptic ulcer; gastritis; renal failure; neuropsychiatric disorders; opium abuse; neuropsychiatric medications; presenting drug adverse effects.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 12 and 24h, 3 and 7 days after operation. Method of measurement: Visual Analogue Scale.;Pethidine consumption. Timepoint: First 24 h post operation, total dosages during admission. Method of measurement: The number of dosages as patient request (according to his weight).;Oral analgesic (gellofen) consumption. Timepoint: Till 3 rd and till 7 th dad post operation. Method of measurement: The count of capsuls consumption.

Secondary

MeasureTime frame
Drug adverse effects. Timepoint: 12 and 24 h post operation, 3 and 7 days post op. Method of measurement: Filling the data collecting form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Salehi

Zanjan University of Medical Siences

sums78_vhds@yahoo.com; sums78vhds@gmail.com+98 24 3313 0001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026